Singapore-based medtech company Advent Access has raised S$2.6 million (US$1.9 million) pre-Series A financing led by Accuron MedTech, the largest medical device company in southeast Asia. It is the largest pre-Series A financing round by a medtech startup across the region.
The investment was made through the Med Tech Alliance, an accelerator appointed by Singapore’s SPRING SEEDS Capital to facilitate the growth of start-ups in the local medtech industry.
Funds raised will be used to advance the development and commercialisation of its technology for vascular access in dialysis patients.
“We are excited to lead the pre- Series A investment in Advent Access given the company’s strong progress and potential to transform and optimise how care is provided to patients in the S$100 billion global dialysis market,” said Abel Ang, group chief executive of Accuron MedTech.